title: Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.
authors.affiliation: Perinatal Institute, Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
authors.forename: Jason R
authors.initials: JR
authors.lastname: Wiles
authors.affiliation: Department of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH.
authors.forename: Barbara
authors.initials: B
authors.lastname: Isemann
authors.affiliation: Perinatal Institute, Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
authors.forename: Laura P
authors.initials: LP
authors.lastname: Ward
authors.affiliation: Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
authors.forename: Alexander A
authors.initials: AA
authors.lastname: Vinks
authors.affiliation: Perinatal Institute, Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH. Electronic address: henry.akinbi@cchmc.org.
authors.forename: Henry
authors.initials: H
authors.lastname: Akinbi
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D009293:Opioid-Related Disorders; D011247:Pregnancy; D011248:Pregnancy Complications
chemical_list: D000701:Analgesics, Opioid